Business Description
Nasus Pharma Ltd. is an Israeli pharmaceutical company founded in 2019 and headquartered in Tel Aviv, focused on developing nasal spray medicines for life-threatening emergencies. Its two lead products are a nasal spray version of epinephrine for treating severe allergic reactions and a nasal powder spray of naloxone for reversing opioid overdoses. The company's approach aims to make critical emergency treatments faster and easier to administer.
